Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Astellas Bows Out Of The CVT Sweepstakes, But What’s Next?

This article was originally published in PharmAsia News

Executive Summary

Usually, having more money that you know how to use is not considered a problem, but cash-rich Astellas may feel a bit stranded now that Gilead has trumped its bid to buy CV Therapeutics. But at least one analyst thinks the U.S. biotech sector still offers plenty of potential acquisitions for the Japanese pharma
Advertisement

Related Content

Japan's Western M&A Targets Drying Up? Astellas-OSI Bid Underscores Hostile Pressures - BIO Asia
Astellas Forecasts Earnings Decline; Says Urology Franchise Will Drive Global Growth
Astellas Pharma Branches Out In U.S., Offers Career-building Workshops To Employees
Astellas Bows Out Of The CVT Sweepstakes, But What’s Next?
CVT And Gilead Look To Lock Out Astellas With Planned Merger
CVT And Gilead Look To Lock Out Astellas With Planned Merger
Telavancin’s “Complete Response” Letter Calls For Pregnancy-Focused REMS
InterMune Bullish On Pirfenidone NDA Despite Mixed Study Results
Troubled Biotechs: Akesis, Metabasis, Xoma, Neurobiological Technologies
Astellas/Cardiome Schedule Kynapid Meeting With U.S. FDA
Advertisement
UsernamePublicRestriction

Register

SC071118

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel